Trial intelligence / Profile preview

RSV challenge study of upper respiratory tract microbiome diversity in healthy adults

NL-OMON51223Not yet recruiting

Sponsor
University Medical Center Utrecht
Start
Jun 2021
Countries
1
01

Overview

Open-label, single-arm trial in respiratory syncytial virus disease (RSV), sponsored by University Medical Center Utrecht. Primary endpoint: Mean Shannon index. Planned start Jun 2021; status: not yet recruiting.

02

Conditions

respiratory syncytial virus disease (RSV)

Beyond the preview

Go deeper on NL-OMON51223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON51223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call